{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:43:54Z","timestamp":1790963034580,"version":"4.1.0"},"reference-count":39,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Penile cancer is a rare condition and can be very complex to manage. Advances in surgical techniques, imaging, pathological classification and patient pathways have led to improved patient care. The diagnosis of pre-malignant change, penile cancer and metastatic disease along with advances in their treatment are detailed in this review which aims to update clinicians from multiple specialties and countries on penile cancer.<\/ns4:p>","DOI":"10.12688\/f1000research.18185.1","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T06:10:11Z","timestamp":1556259011000},"page":"558","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Recent advances in the management of penile cancer"],"prefix":"10.12688","volume":"8","author":[{"given":"Maximilian J","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0750-2719","authenticated-orcid":false,"given":"Raj","family":"Nigam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"803-8","DOI":"10.1016\/j.juro.2012.05.012","article-title":"Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control.","volume":"188","author":"P Philippou","year":"2012","journal-title":"J Urol."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"652-7","DOI":"10.1111\/j.1464-410X.1994.tb09200.x","article-title":"Quality of life in patients treated for penile cancer. A follow-up study.","volume":"74","author":"S Opjordsmoen","year":"1994","journal-title":"Br J Urol."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"560-9","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.","volume":"73","author":"G Paner","year":"2018","journal-title":"Eur Urol."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"22-6","DOI":"10.1111\/bju.14532","article-title":"Penile cancer information on the internet: a needle in a haystack.","volume":"122 Suppl 5","author":"J Teh","year":"2018","journal-title":"BJU Int."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"796-802","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.","volume":"87","author":"F Bosch","year":"1995","journal-title":"J Natl Cancer Inst."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(16)31266-1","article-title":"Expanding the benefits of HPV vaccination to boys and men.","volume":"388","author":"P Doiron","year":"2016","journal-title":"Lancet."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"791-802","DOI":"10.21037\/tau.2017.06.27","article-title":"Relationship between human papillomavirus and penile cancer-implications for prevention and treatment.","volume":"6","author":"L Kidd","year":"2017","journal-title":"Transl Androl Urol."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"161-9","DOI":"10.1177\/1756287212465456","article-title":"Primary prevention and vaccination for penile cancer.","volume":"5","author":"M Shabbir","year":"2013","journal-title":"Ther Adv Urol."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"b3884","DOI":"10.1136\/bmj.b3884","article-title":"Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States.","volume":"339","author":"J Kim","year":"2009","journal-title":"BMJ."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"96-102","DOI":"10.1053\/j.semdp.2011.08.009","article-title":"Histologic classification of penile intraepithelial neoplasia.","volume":"29","author":"E Velazquez","year":"2012","journal-title":"Semin Diagn Pathol."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"481-495","DOI":"10.3322\/caac.21354","article-title":"Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies.","volume":"66","author":"P Spiess","year":"2016","journal-title":"CA Cancer J Clin."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"721-3","DOI":"10.1038\/s41585-018-0083-0","article-title":"Immunotherapy for advanced penile cancer - rationale and potential.","volume":"15","author":"B McGregor","year":"2018","journal-title":"Nat Rev Urol."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"6-9","DOI":"10.1097\/01.XHA.0000423421.22785.86","article-title":"Penile intraepithelial neoplasia: management and outcomes.","volume":"3","author":"A Zreik","year":"2013","journal-title":"Human Andrology."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"923-8","DOI":"10.1016\/j.eururo.2012.02.052","article-title":"Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents.","volume":"62","author":"H Alnajjar","year":"2012","journal-title":"Eur Urol."},{"key":"ref-15","article-title":"EAU Guidelines on Penile Cancer","author":"O Hakenberg","year":"2018"},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"693-6","DOI":"10.1016\/j.urolonc.2011.02.013","article-title":"Dynamic sentinel lymph node biopsy as the new paradigm for the management of penile cancer.","volume":"31","author":"L Yeung","year":"2013","journal-title":"Urol Oncol."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"1176-84","DOI":"10.1007\/s00259-017-3636-1","article-title":"Investigating the role of SPECT\/CT in dynamic sentinel lymph node biopsy for penile cancers.","volume":"44","author":"Z Saad","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"833-8","DOI":"10.21037\/tau.2017.04.36","article-title":"The role of PET\/CT imaging in penile cancer.","volume":"6","author":"S Ottenhof","year":"2017","journal-title":"Transl Androl Urol."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"330-9","DOI":"10.1245\/s10434-016-5461-3","article-title":"Morbidity After Inguinal Lymph Node Dissections: It Is Time for a Change.","volume":"24","author":"M Faut","year":"2017","journal-title":"Ann Surg Oncol."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"196-201","DOI":"10.1111\/bju.13009","article-title":"Predicting postoperative complications of inguinal lymph node dissection for penile cancer in an international multicentre cohort.","volume":"116","author":"J Gopman","year":"2015","journal-title":"BJU Int."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"530-4","DOI":"10.1111\/bju.13660","article-title":"Prospective study comparing video-endoscopic radical inguinal lymph node dissection (VEILND) with open radical ILND (OILND) for penile cancer over an 8-year period.","volume":"119","author":"V Kumar","year":"2017","journal-title":"BJU Int."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"363-6","DOI":"10.1007\/s11255-015-1182-y","article-title":"Saphenous vein sparing during laparoscopic bilateral inguinal lymphadenectomy for penile carcinoma patients.","volume":"48","author":"Y Cui","year":"2016","journal-title":"Int Urol Nephrol."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"826-32","DOI":"10.21037\/tau.2017.06.05","article-title":"Robotic inguinal lymphadenectomy for penile cancer: the why, how, and what.","volume":"6","author":"S Elsamra","year":"2017","journal-title":"Transl Androl Urol."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"439-43","DOI":"10.1111\/bju.13041","article-title":"The accuracy of magnetic resonance imaging (MRI) in predicting the invasion of the tunica albuginea and the urethra during the primary staging of penile cancer.","volume":"117","author":"V Hanchanale","year":"2016","journal-title":"BJU Int."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"204-9","DOI":"10.1308\/003588412X13171221501906","article-title":"The development of a supraregional network for the management of penile cancer.","volume":"94","author":"P Kumar","year":"2012","journal-title":"Ann R Coll Surg Engl."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"702-11","DOI":"10.1038\/nrurol.2014.307","article-title":"Challenges and controversies in the management of penile cancer.","volume":"11","author":"M Shabbir","year":"2014","journal-title":"Nat Rev Urol."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"1097-103","DOI":"10.1016\/j.urology.2014.11.048","article-title":"Oncologic Outcomes of Penile Cancer Treatment at a UK Supraregional Center.","volume":"85","author":"R Veeratterapillay","year":"2015","journal-title":"Urology."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"1040-3","DOI":"10.1111\/j.1464-410X.2005.05769.x","article-title":"What surgical resection margins are required to achieve oncological control in men with primary penile cancer?","volume":"96","author":"S Minhas","year":"2005","journal-title":"BJU Int."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"284-9","DOI":"10.1016\/j.eururo.2016.09.048","article-title":"Glansectomy and Split-thickness Skin Graft for Penile Cancer.","volume":"73","author":"A Parnham","year":"2018","journal-title":"Eur Urol."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"1293-7","DOI":"10.1007\/s00120-017-0478-1","article-title":"Zentralisierung der Harnr\u00f6hre und Pseudoglansbildung nach partieller Penektomie.","volume":"56","author":"J Kranz","year":"2017","journal-title":"Urologe A."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"852-6","DOI":"10.1111\/j.1464-410X.2009.08424.x","article-title":"Total phallic reconstruction after penile amputation for carcinoma.","volume":"104","author":"G Garaffa","year":"2009","journal-title":"BJU Int."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"141-6","DOI":"10.1016\/j.urolonc.2017.07.025","article-title":"Predictive factors for local recurrence after glansectomy and neoglans reconstruction for penile squamous cell carcinoma.","volume":"36","author":"M Albersen","year":"2018","journal-title":"Urol Oncol."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"76-83","DOI":"10.1016\/j.eururo.2018.04.003","article-title":"Risks and Benefits of Adjuvant Radiotherapy After Inguinal Lymphadenectomy in Node-positive Penile Cancer: A Systematic Review by the European Association of Urology Penile Cancer Guidelines Panel.","volume":"74","author":"R Robinson","year":"2018","journal-title":"Eur Urol."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"605.e17-605.e23","DOI":"10.1016\/j.urolonc.2017.06.001","article-title":"Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: A multi-institutional study.","volume":"35","author":"D Tang","year":"2017","journal-title":"Urol Oncol."},{"key":"ref-35","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2018.10.007","article-title":"Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes.","author":"P Johnstone","year":"2018","journal-title":"Eur Urol Focus."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"1387-95","DOI":"10.1016\/j.juro.2017.01.059","article-title":"Penile Cancer: Contemporary Lymph Node Management.","volume":"197","author":"J O'Brien","year":"2017","journal-title":"J Urol."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"37-40","DOI":"10.1111\/j.1464-410X.2007.06582.x","article-title":"Vertical rectus abdominis flap reconstruction in patients with advanced penile squamous cell carcinoma.","volume":"99","author":"O Kayes","year":"2007","journal-title":"BJU Int."},{"key":"ref-38","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2018.02.002","article-title":"Surgical and Oncological Outcomes in Patients After Vascularised Flap Reconstruction for Locoregionally Advanced Penile Cancer.","author":"S Ottenhof","year":"2018","journal-title":"Eur Urol Focus."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"S13-S21","DOI":"10.21037\/tau.2019.01.05","article-title":"Long-term outcomes for penile cancer patients presenting with advanced N3 disease requiring a myocutaneous flap reconstruction or primary closure\u2014a retrospective single centre study.","volume":"8","author":"H Alnajjar","year":"2019","journal-title":"Transl Androl Urol."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/8-558\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/8-558\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/8-558\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T06:20:09Z","timestamp":1556259609000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/8-558\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":39,"URL":"https:\/\/doi.org\/10.12688\/f1000research.18185.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.19892.r47344","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.19892.r47345","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,26]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/8-558\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.19892.r47344, Oliver W Hakenberg, Department of Urology, University of Rostock, Rostock, Germany, 26 Apr 2019, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/8-558\/v1#referee-response-47344","order":0,"name":"referee-response-47344","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.19892.r47345, Nathan Lawrentschuk, Department of Surgery, University of Melbourne, Victoria, Australia, 26 Apr 2019, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/8-558\/v1#referee-response-47345","order":1,"name":"referee-response-47345","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}